EGFR and IGF-1R activation has been shown to increase cell proliferation, inhibit apoptosis, induce resistance to chemotherapy and increase Mycn protein levels in neuroblastoma [8]–[13]. This evidence concerns the gene MYCN and neuroblastoma.